Pereira Alberto M, van Thiel Sjoerd W, Lindner Jonathan R, Roelfsema Ferdinand, van der Wall Ernst E, Morreau Hans, Smit Jan W A, Romijn Johannes A, Bax Jeroen J
Department of Endocrinology and Metabolism, Leiden University Medical Center, 2300 RC Leiden, The Netherlands.
J Clin Endocrinol Metab. 2004 Jan;89(1):71-5. doi: 10.1210/jc.2003-030849.
Cardiac involvement is common in acromegaly, but the prevalence of valvular abnormalities in patients with acromegaly has not been documented and is the topic of this study. In a prospective study design, 40 consecutive patients with acromegaly and 120 control subjects (matched for age, sex, hypertension, and left ventricular systolic function) were studied. All patients and controls were evaluated using conventional two-dimensional and Doppler echocardiography. Significant valve disease was more prevalent in acromegalics compared with controls (22% vs. 6.7%, respectively; P = 0.005). Aortic valve regurgitation (>/=>trace severity) was present in 30% of patients vs. 7% of controls (P < 0.001), and mitral regurgitation (>/=moderate severity) was absent in controls but present in 5% of acromegalics (P = 0.014 vs. controls). Binary logistic regression analysis showed a significant impact only for disease duration on valvular disease, with an odds ratio of 1.19 (95% confidence interval, 1.028-1.376; P = 0.019). Acromegaly is associated with an increased prevalence of regurgitant valvular heart disease. This is dependent on the duration of exposure to increased GH concentrations, with a 19% increase in odds per year. This increased prevalence of occult valvular disease indicates that these patients require appropriate follow-up care and monitoring, especially patients with inadequate control of GH overproduction.
心脏受累在肢端肥大症中很常见,但肢端肥大症患者瓣膜异常的患病率尚无文献记载,本研究即围绕这一主题展开。在一项前瞻性研究设计中,对40例连续的肢端肥大症患者和120名对照者(按年龄、性别、高血压和左心室收缩功能匹配)进行了研究。所有患者和对照者均采用传统二维和多普勒超声心动图进行评估。与对照组相比,显著瓣膜疾病在肢端肥大症患者中更为普遍(分别为22%和6.7%;P = 0.005)。30%的患者存在主动脉瓣反流(≥微量严重程度),而对照组为7%(P < 0.001),对照组无二尖瓣反流(≥中度严重程度),而5%的肢端肥大症患者存在二尖瓣反流(与对照组相比,P = 0.014)。二元逻辑回归分析显示,仅疾病持续时间对瓣膜疾病有显著影响,优势比为1.19(95%置信区间,1.028 - 1.376;P = 0.019)。肢端肥大症与反流性瓣膜性心脏病患病率增加相关。这取决于生长激素浓度升高的暴露持续时间,每年优势增加19%。隐匿性瓣膜疾病患病率的增加表明这些患者需要适当的随访护理和监测,尤其是生长激素分泌过多控制不佳的患者。